Cellectis (CLLS) Change in Inventory (2016 - 2021)
Cellectis (CLLS) posted Change in Inventory of $289000.0 for Q4 2021, down 63.51% on a QoQ basis from $792000.0 in Q3 2021, and down 91.63% year-over-year from $3.5 million in Q4 2020.
Cellectis (CLLS) has 6 years of Change in Inventory data on file, last reported at $289000.0 in Q4 2021.
- In Q4 2021, Change in Inventory fell 91.63% year-over-year to $289000.0; the TTM figure through Dec 2021 stood at $215000.0 (up 115.0% YoY), while the FY2021 annual figure was $215000.0, up 115.0% from the prior year.
- Change in Inventory fell to $289000.0 in Q4 2021, from $792000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $3.5 million in Q4 2020 and bottomed at -$3.7 million in Q1 2021.
- A 5-year average of -$122889.8 and a median of -$898.2 in 2017 frame the typical range for Change in Inventory.
- The widest YoY moves for Change in Inventory: up 953.57% in 2019, down 34328.57% in 2019.
- Year by year, Change in Inventory stood at -$116000.0 in 2017, then soared by 51.72% to -$56000.0 in 2018, then jumped by 953.57% to $478000.0 in 2019, then surged by 622.38% to $3.5 million in 2020, then plunged by 91.63% to $289000.0 in 2021.
- The last three Change in Inventory figures came in at $289000.0 (Q4 2021), $792000.0 (Q3 2021), and $2.9 million (Q2 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 665.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 97.70 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -26.60 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 3.32 Mn |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 289,000.00 |
| Dec 31, 2021 | 289,000.00 |
| Sep 30, 2021 | 792,000.00 |
| Sep 30, 2021 | 792,000.00 |
| Jun 30, 2021 | 2.87 Mn |
| Jun 30, 2021 | 2.87 Mn |
| Mar 31, 2021 | -3.74 Mn |
| Mar 31, 2021 | -3.74 Mn |
| Dec 31, 2020 | 3.45 Mn |
| Dec 31, 2020 | 3.45 Mn |
| Sep 30, 2020 | -540,000.00 |
| Sep 30, 2020 | -540,000.00 |
| Jun 30, 2020 | -2.11 Mn |
| Jun 30, 2020 | -2.11 Mn |
| Mar 31, 2020 | -702,000.00 |
| Mar 31, 2020 | -702,000.00 |
| Dec 31, 2019 | 478,000.00 |
| Dec 31, 2019 | 478,000.00 |
| Sep 30, 2019 | -2.40 Mn |
| Sep 30, 2019 | -2.40 Mn |
| Jun 30, 2019 | 79,000.00 |
| Jun 30, 2019 | 79,000.00 |
| Mar 31, 2019 | -788,000.00 |
| Mar 31, 2019 | -788,000.00 |
| Dec 31, 2018 | -56,000.00 |
| Dec 31, 2018 | -56,000.00 |
| Sep 30, 2018 | 7,000.00 |
| Sep 30, 2018 | 7,000.00 |
| Jun 30, 2018 | -42,000.00 |
| Jun 30, 2018 | -42,000.00 |
| Mar 31, 2018 | 54,000.00 |
| Mar 31, 2018 | 54,000.00 |
| Dec 31, 2017 | -116,000.00 |
| Dec 31, 2017 | -116,000.00 |
| Sep 30, 2017 | 9,000.00 |
| Sep 30, 2017 | 9,000.00 |
| Jun 30, 2017 | -8,796.39 |
| Jun 30, 2017 | -8,796.39 |
| Mar 31, 2017 | 7,000.00 |
| Mar 31, 2017 | 7,000.00 |
| Dec 31, 2016 | -8,000.00 |
| Dec 31, 2016 | -8,000.00 |
| Sep 30, 2016 | 22,323.69 |
| Sep 30, 2016 | 22,323.69 |
| Jun 30, 2016 | -24,857.25 |
| Jun 30, 2016 | -24,857.25 |
| Mar 31, 2016 | 59,562.66 |
| Mar 31, 2016 | 59,562.66 |